Connect with us

CBD

Hemplucid CBD Gummies

Hemplucid CBD Gummies are created with a proprietary formula to enhance bio-accessibility. Each bear shaped gummie is loaded with terpenes. Although they are cute, they contain 25mg of ultra-refined, full spectrum CBD oil. Half of a gummie bear is the recommended dosage to those who are sensitive or new edible CBD users.

Republished by Plato

Published

on

Hemplucid CBD Gummies are created with a proprietary formula to enhance bio-accessibility. Each bear shaped gummie is loaded with terpenes. Although they are cute, they contain 25mg of ultra-refined, full spectrum CBD oil. Half of a gummie bear is the recommended dosage to those who are sensitive or new edible CBD users.

Source: https://painfreehempoil.blogspot.com/2017/05/hemplucid-cbd-gummies.html

CBD

CBD for Fibromyalgia: Can CBD Really Help?

According to the CDC, roughly 4 million US adults are affected by fibromyalgia. Although researchers don’t fully understand the cause of fibromyalgia, there are means of treatment available. The unknowns of this condition have left many people asking the question: can CBD help with fibromyalgia? This question should come as no surprise considering that research… View Article

The post CBD for Fibromyalgia: Can CBD Really Help? appeared first on The CBD Insider.

Republished by Plato

Published

on

cbd for fibromyalgia

According to the CDC, roughly 4 million US adults are affected by fibromyalgia. Although researchers don’t fully understand the cause of fibromyalgia, there are means of treatment available. The unknowns of this condition have left many people asking the question: can CBD help with fibromyalgia?

This question should come as no surprise considering that research indicates CBD may alleviate the most common fibromyalgia symptoms, which the CDC reports as:

  • Pain and stiffness
  • Fatigue
  • Depression
  • Anxiety
  • Sleep problems
  • Cognitive issues
  • Headaches/migraines

If you’re remotely familiar with CBD, you likely recognize an overlap between its potential benefits and these common fibromyalgia symptoms.

CBD for Fibromyalgia: Table of Contents

  1. A Look into the Research of CBD for Fibromyalgia
  2. Other Potential Benefits of CBD
  3. What is CBD?
  4. CBD Risks and Side Effects
  5. Conclusion

A Look into the Research of CBD for Fibromyalgia

Current research on the potential of CBD for fibromyalgia relief is severely limited. However, the results of the few studies that have been conducted show enough evidence for scientists to continue studying this subject.

Journal of Clinical Medicine 2019: Cannabis and Fibromyalgia

In a 2019 study published by the Journal of Clinical Medicine, researchers observed several hundred participants diagnosed with fibromyalgia for a minimum of six months. Since women are twice as likely to develop fibromyalgia as men, 82% of participants were female.

This study explored the benefits medical cannabis may provide for patients diagnosed with fibromyalgia. Although the medical cannabis used in the study contained both THC and CBD, the results provided a view into how cannabinoids may play a role in alleviating fibromyalgia symptoms.

Participants were initially given a low dose of medical cannabis. Over the course of six months, researchers titrated the dosage given to participants. The average starting dosage was 670mg/day, and by the six-month mark, the average medical cannabis dosage was 1,000mg/day. This resulted in participants being exposed to a daily average of 140mg of THC and 39mg of CBD.

This study did not come without a few limitations. Researchers stated that “this study was observational in nature and could not establish causality between medical cannabis use and improvement in fibromyalgia outcomes.” In other words, they were unable to definitively state that observed results were directly due to participants using medical cannabis because the study was neither randomized nor controlled.

Secondly, researchers faced issues with participants who were unwilling to follow-up after the initial six-month trial period. A 30% non-respondent rate was reported, which may have resulted in a non-response bias.

Lastly, the study was designed to incorporate 14 various medical cannabis strains. According to researchers, “this prevented [researchers] from conducting a comparison between THC and CBD strains and products in terms of effectiveness and safety.”

Limitations aside, the data collected was still grounds for researchers to deem medical cannabis a potentially “effective and safe treatment to fibromyalgia.” Additionally, the results of this study “highlight the need for further research.”

Overall, 52.5% of the study participants initially reported their pain level as “high”; however, after six months of treatment, the number of participants reporting “high” levels of pain was reduced to 7.9%.

International Association for the Study of Pain 2019: THC, CBD and Fibromyalgia

In a similar but much smaller study (n=20) published by the Journal of International Association for the Study of Pain, researchers explored medical cannabis use in fibromyalgia cases. This study varied from the aforementioned research by documenting how various THC:CBD ratios affected patient outcomes.

Participants were provided with four variations of medical cannabis. These variations included a placebo dose (containing no THC or CBD), a dose containing both high THC and CBD, a low THC/high CBD dose, and a high THC/low CBD dose.

The results of the study revealed that high CBD/low THC products were not successful in alleviating fibromyalgia pain. However, those using high THC/low CBD products reported a notable improvement in their pressure/pain threshold.

Here is where things get interesting for CBD. Although the high CBD/low THC products proved ineffective, 90% of participants reported a 30% improvement in spontaneous pain when using a product containing high concentrations of both CBD and THC.

Overall, researchers concluded that more research is required to understand the complexities of THC/CBD’s role in pain reduction though early evidence shows CBD alone may not be effective in treating fibromyalgia pain. That said, it is important to remember that this was a relatively small study and certainly not comprehensive evidence. 

Other Potential Benefits of CBD 

The growing list of potential CBD benefits makes this naturally occurring, non-intoxicating cannabinoid seem too good to be true at first glance, but results from studies around the world are beginning to back up some of these claims.

Many of the benefits touted by CBD users are only supported by anecdotal evidence at this time. That said, the amount of positive user experiences, like many of those reported in our 2019 US CBD Consumer Report, has garnered the attention of researchers worldwide.

In our survey of over 1,000 individuals, users reported the following regarding their experience with CBD:

  • 82.4% of those using CBD for energy reported CBD being very or extremely effective for increasing energy
  • 79.5% of those using CBD for mood reported CBD being very or extremely effective for mood regulation
  • 78.9% of those using CBD for relaxation reported CBD being very or extremely effective for relaxation
  • 76.8% of those using CBD for sleep reported CBD being very or extremely effective in helping them sleep
  • 67.4% of those using CBD for aches/discomfort reported CBD being very or extremely effective in providing relief from aches/discomfort

If we look at the controlled study results currently available, we can see additional reason to believe CBD has a lot of potential.

In a study published in the Brazilian Journal of Psychiatry, researchers concluded that “CBD seems to produce its anxiolytic effects through receptors in the serotonergic system.” If you suffer from anxiety, you should check out our article that takes a deep-dive into using CBD for relief.

Another use case that has captured the attention of many is CBD’s potential to provide pain relief. Numerous studies have explored CBD as a pain treatment option with promising results. If you suffer from pain or have found yourself reaching for opioids, we recommend checking out our comprehensive piece on CBD’s potential to alleviate pain.   

What is CBD?

Cannabidiol or CBD is a naturally occurring compound produced by the cannabis plant. This cannabinoid is closely related to THC; however, CBD does not produce any intoxicating or psychoactive effects.

CBD’s non-addictive and non-habit forming properties, a growing list of potential benefits, and removal from the DEA’s controlled substances list are all contributing factors to its rapid rise in popularity.

CBD is widely available in most retailers around the nation. Manufacturers have created a litany of CBD products for consumers to choose from. Currently, CBD-infused product offerings include tinctures, vapes, edibles, patches, capsules, creams, smokable flower, and much more. 

CBD Risks and Side Effects 

Like most things, users should be informed of the potential side effects and risks associated with CBD use.

Contraindications

CBD users who also use or plan on using other OTC or Rx medications should discuss the potential for interactions with their medical provider.

CBD utilizes the Cytochrome P450 enzyme which is produced by the liver. This enzyme is responsible for metabolizing or breaking down CBD into a form that our bodies can use.

The potential for contraindications may surface when a CBD user takes another medication that also utilizes CYP enzymes in order to reach systemic circulation. An estimated 70-80% of modern medications rely on CYP enzymes.

Side Effects

CBD is commonly thought of as free of side effects, but this isn’t entirely true. Reports of side effects associated with CBD are generally deemed mild.

In a study published by the Journal of Cannabis and Cannabinoid Research, the most commonly reported side effects associated with CBD use include sleepiness, changes in appetite/weight, and diarrhea.

That said, the same study also comments, “in comparison with other drugs, used for treatment of these medical conditions, CBD has a better side effect profile.” [13]

Limited Research

Although there are currently over 300 clinical trials underway involving CBD, there is limited information that has already been published.

This is due in part to CBD’s rapid rise in popularity coupled with the removal of many regulatory hurdles with the passing of the 2018 Farm Bill.

All current and potential CBD users should remember that a lot of evidence behind CBD’s potential is anecdotal. This isn’t intended to discourage users from trying CBD but instead, to serve as a reminder that just because CBD works for one person, doesn’t necessarily mean it will work for everyone. Hopefully, as more research becomes available, scientists will develop a better understanding of CBD’s mechanisms of action.

Is My CBD Product High-Quality? 

It probably comes as no surprise that, like most industries, there are some shady brands in the CBD space. Without additional regulation, the burden remains on the individual to ensure they’re using a high-quality CBD product from a reputable brand.

We recognize the headache this can be for many users. That’s what led us to create our CBD Knowledge Center. This free resource is filled with countless tips and guides to help you get the most out of your CBD purchases.

Additionally, we’ve implemented a Trusted Brands tool. This is a free tool where users can compare the pros and cons of CBD brands that we’ve thoroughly vetted for quality.

If you’re looking for a tip, we recommend checking for your product’s certificate of analysis (COA). COAs are documents provided to brands by third-party labs. COAs provide information regarding your product’s contents as well as the presence of potential toxins (heavy metals, pesticides, mold, etc.).

Every CBD product should have a matching COA available. If you’re unable to find a COA for your product on the brand’s website or if they’re unwilling to provide a copy of the COA, this is a major red flag and a reason to find a new CBD brand.

Another thing that all CBD users should check for is proper labeling. If the information on your product’s label seems vague or there appears to be a lot of room for interpretation regarding contents, dosage, or directions, we recommend reaching out to the brand through their website or social media for further clarification.

Overall, users should remember that a reputable CBD brand will always be happy to provide a COA for any of their products and discuss any questions you may have.

Conclusion 

Preliminary research presents a mixed bag in terms of CBD’s ability to provide relief from fibromyalgia symptoms. With the hundreds of CBD-based clinical trials in progress, we suspect researchers will be able to provide a more definitive answer into CBD’s potential to help those suffering from fibromyalgia.

If you are currently battling fibromyalgia and want to try CBD, we recommend first speaking with your medical provider to develop a monitoring plan and discuss any changes to keep an eye out for.

We also recommend signing up for our free newsletter. This is a great resource for the latest CBD news, research findings, and product reviews.

The CBD Insider Editorial Team

The mission of The CBD Insider is to provide consumers with a way to find high-quality, safe, and well-formulated CBD products. Our editorial team of passionate industry professionals achieves this mission by providing unbiased, trustworthy, and well-researched reporting about the CBD industry.

Source: https://thecbdinsider.com/knowledge-center/cbd-for-fibromyalgia-can-cbd-really-help/

Continue Reading

CBD

CBD News: Raw cannabis materials, supply chain and design key to choosing vaping hardware

Quality raw materials, redundant supply-chain relationships and design are keys to creating a safe, reliable CBD vape product.

Raw cannabis materials, supply chain and design key to choosing vaping hardware is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

From Raw cannabis materials, supply chain and design key to choosing vaping hardware on CBD Products & CBD Business News – Hemp Industry Daily.

This was autoposted by IFTTT. To find out more, read my post about news articles.

Republished by Plato

Published

on

Quality raw materials, redundant supply-chain relationships and design are keys to creating a safe, reliable CBD vape product.

Raw cannabis materials, supply chain and design key to choosing vaping hardware is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

From Raw cannabis materials, supply chain and design key to choosing vaping hardware on CBD Products & CBD Business News – Hemp Industry Daily.

This was autoposted by IFTTT. To find out more, read my post about news articles.

Source: http://blog.hempcbd.business/2020/10/cbd-news-raw-cannabis-materials-supply.html

Continue Reading

CBD

Will Europe THC Limit Increase to 0.3%?

Big day for European hemp farmers and the CBD industry as the allowance of THC in industrial hemp was voted on by Parliament. While still low compared to countries like Switzerland, this Europe THC limit increase would certainly loosen things up. A lot goes on in the world of legal cannabis. Sign-up to our newsletter […]

The post Will Europe THC Limit Increase to 0.3%? appeared first on CBD Testers.

Republished by Plato

Published

on

Big day for European hemp farmers and the CBD industry as the allowance of THC in industrial hemp was voted on by Parliament. While still low compared to countries like Switzerland, this Europe THC limit increase would certainly loosen things up.

A lot goes on in the world of legal cannabis. Sign-up to our newsletter to always be in-the-loop.

Hemp farmers in Europe have been pushing for change for quite some time. The .2% THC limit that was instituted many years ago has been making it difficult, and decreasing the amount of strains possible to use. Now, Parliament has voted to increase that maximum to .3%, included in the Common Agricultural Policy reform. But will it actually go through?

Where did .2% come from?

The first time a standard was set for a Europe THC limit in industrial hemp, was in 1984 when it was put at .5%. This was lowered in the 1970’s to .3%. At that time, .3% was the line that separated low-THC hemp (usually high-CBD flowers, but also high-CBG strains exist) and high-THC cannabis. In 1999 this dropped down again to the .2% that its been since, with the original aim being to prevent high-THC marijuana from being grown in low-THC industrial hemp fields. The proposal to increase the THC limit is not new, and has been pushed for quite some time.

thousands of years with plenty of evidence for how, when, and where. Yet it’s mainly treated like this history is meaningless, with paid-for research studies being the bottom line, when often they are not. This inability to learn from history is frustrating, and it becomes all the more obvious how much of an issue it is, when Europe makes arguments about not raising a THC limit to a level it had already functioned perfectly at for years.

It should also be noted that while this vote was made nearly a week ago, that no large publications have covered it all. In fact, the only publications to cover the news are hemp-related.

Why it matters

If a person didn’t know much about cannabis, they might expect that THC could simply be removed at whatever percentage is necessary. Unfortunately, that’s not how it works, and different strains of hemp have different amounts of THC. Not only that, CBD often goes up in proportion to THC, meaning that a lot of strains have been counted out since in order to get the level of CBD, it would mean accepting over .2% THC. While raising to .3% doesn’t make it all inclusive, it would make it so that more strains can be grown.

Is it a done deal?

decision does not rely solely on Parliament. The policy for adopting and/or amending legislation in the EU is for three different bodies to approve, or come to some decision. The vote last week was not to pass legislation, but merely to establish the opinion of Parliament on the Common Agricultural Policy reform proposal.

In order for it to actually go into effect, there are two more bodies that have to approve: The Council of the European Union and the European Commission. The three bodies are slated to begin negotiations on the agricultural policy reforms come mid-November. This assuming that issues related to the Coronavirus don’t force postponements.

What are the reforms?

A broad-ranging agricultural policy includes all kinds of laws, however the only ones of concern here, are the ones related to growing hemp. The two amendments to the Common Agricultural Policy of note to cannabis-news followers are these:

  • Amendments 8 & 93 – to raise the current allowable THC amount in industrial hemp from .2% to .3%.
  • Amendment 234 – Allows hemp to be covered by marketing standards for the EU so that products can eventually be graded according to appearance, consistency, characteristics, and restrictions. This includes labeling, packaging, production methods, etc.
2019, the EU amended its Novel Food Catalogue to include extracts of cannabis sativa L. like CBD. Being added to this category means that cannabis extracts are considered to have no demonstrable history of consumption. Looking at history, we know this isn’t actually true at all, but once again, history was ignored in favor of regulation tactics. Though the Novel Food regulation isn’t binding, most countries seem to go by it as a rule, and it could very well be that Europe pressures them to do so (though this is only supposition). Before any product can be placed on the market, it requires a safety assessment under Novel Food regulation (which again, isn’t actually binding).

Prior to 2019, extracts of cannabis in which CBD had higher levels than in the actual plant were considered novel, but nothing else. Cannabis sativa L. could be grown at that time so long as the specific strain was registered in the EU “Common Catalogue of Varieties of Agricultural Plant Species”, and with a THC level not above .2%. Essentially, adding cannabis extracts to the Novel Food list made it that much more restrictive to sell CBD products. Though this new update to the Common Agricultural Policy wouldn’t exclude hemp from Novel Food regulation (which is about to be updated again), it would at least ease some of the restrictions that are put on it, and the products that can come out of it. When an industry is so restrictive on so many fronts, any amount of loosening of the rules allows for more general freedom.

The European Industrial Hemp Association is viewing the parliamentary vote as a success, and in a way it is, but it’s not the end of the story. These updates do not have to be approved, or used, if the two other governing bodies decide they’re out of line. In this way, this vote is really just a stepping stone in a much longer process, for which it’s still impossible to know the ending.

Conclusion

It’s hard to tell which way legislation will go. Europe tends to lean more towards loosening restrictions than other locations, but at the same time, goes back on itself constantly. Simply adding cannabis extracts to the Novel Food category was a step backwards, made only 1.5 years ago. It might be hard to imagine Europe not taking up the agricultural recommendations, but nothing says it has to either. So while the European Industrial Hemp Association rejoices, it might be a bit soon. When it comes to cannabis regulation, things don’t tend to make sense…nearly anywhere. So expecting a straight line to legalization, is expecting way too much. Maybe the Europe THC limit really will be raised. And maybe it won’t be. But it’s just too soon to say.

Thanks so much for stopping by CBDtesters.co, your one-stop-shop for all cannabis-related news. Stop by regularly to stay up-to-date, and sign up to our newsletter so you never miss a beat.

Resources

Everything You Need To Know About CBD Isolate (a deep look into hemp extracts)
Synthetic Cannabinoids (Are they synthetic cannabinoids safe?)
The Endocannabinoid System Explained (Why Cannabis Is Good for Our Bodies)

Government Assistance Options for U.S. Hemp Farmers Affected By COVID-19
Newest Cannabinoid Powerhouse – CBC – What Can It Do for You?
Cannabinoids 101 – Spotlight on CBN (Cannabinol)

Cannabis Cosmetics: What’s Allowed, What’s Not, and Where to Find Them (What is the latest regulations in Europe and which products are allowed)
Government Assistance Options for U.S. Hemp Farmers Affected By COVID-19
The CBD Flowers Weekly newsletter (your top resource for all things smokable hemp flowers)
Your Complete Guide to EU GMP-Certified CBD Isolate and Distillate (European Market)
EU GMP-Certified Cannabinoid Isolates and Distillates (Why is it so difficult to get EU-GMP raw materials in Europe)
The Medical Cannabis Weekly newsletter (International medical cannabis business report)
The Legal Landscape Of CBD Hemp Flower In Europe

The Delta 8 Weekly Newsletter (All you need to know about Delta 8 thc)Regulators Go After Smokable Hemp Flower – What Does The Future Hold?

Source: https://cbdtesters.co/2020/10/29/will-europe-thc-limit-be-increased-to-3/

Continue Reading
CBD4 days ago

The New Italian Cannabis Contradiction

Heartland4 days ago

Bought Haven St. 150 peace tea. Looking for a review before I brew myself a cup

CBD1 day ago

Will Europe THC Limit Increase to 0.3%?

News4 days ago

Sugarbud Announces Supply Agreement with British Columbia Liquor Distribution Branch

Heartland4 days ago

Who Is Newly Lobbying On Cannabis?

Heartland3 days ago

Dosage recommendation and does it make anyone else feel groggy all day?

Heartland5 days ago

Natures fusions

Heartland5 days ago

CBD Gummies Market Comprehensive Study Explore Huge Growth in Future

Heartland5 days ago

Terp Town

Heartland4 days ago

Vaping CBD flower doesn’t really do anything. Can you vape hash? Is my flower just too weak?

News4 days ago

FluroTech Announces Filing of Patent Applications With Respect to Its Proprietary Diagnostic Test Method and Pandemic Defense Platform

News4 days ago

Rubicon Organics Establishes Route to Market for Cannabis 2.0 Products

Heartland4 days ago

CBD flower and hair testing?

Heartland4 days ago

CBD vs CBN: What’s The Actual Difference?

Heartland4 days ago

What cbd cartridge brand is the best?

Heartland3 days ago

CBG for Crohn’s

Heartland3 days ago

Accountants from Coast to Coast Meet to Discuss Cannabis Issues

Heartland5 days ago

Can I redose after 2 hours?

Heartland5 days ago

Police charge woman after fatal collision in Melbourne CBD

Heartland5 days ago

CBD Skin Care Products Market Size 2020 By Product Types, End-Users, Regional Outlook …

Heartland5 days ago

Researchers Report CBD Appears To Help Reduce Lung Damage From COVID

Material5 days ago

Kinetic modeling of the leaching of LiCoO2 with phosphoric acid

Heartland4 days ago

Canada’s Stubborn Black-Market Cannabis Problem

Heartland4 days ago

Cannabis Tycoon Curaleaf expected to monetize loads after Connecticut Legalizes

News4 days ago

Canada House Wellness Group Enters into Distribution Agreement for Cannabis 2.0 Products

News4 days ago

Canntab to Launch in Australia and Participate in Australia’s Largest Cannabis Research Study

Heartland4 days ago

MMJ Recs Medical Marijuana Cards And Your Privacy: Are MMJ Cards Confidential?

Heartland4 days ago

Exclusive: Colorado’s Governor Jared Polis Talks Legal Cannabis

Heartland3 days ago

CBD Hemp Oil Market Research Report Covers – Product Types, Applications, Market Share …

News3 days ago

EBV Elektronik adds NanoXplore to its linecard

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America